Cargando…
Update on corticosteroids for diabetic macular edema
Diabetic macular edema (DME) remains an important cause of visual loss. Although anti-vascular endothelial growth factor (VEGF) agents are generally used as first-line treatments for patients with center-involving DME, there is an important role for corticosteroids as well. Corticosteroids may be es...
Autores principales: | Schwartz, Stephen G, Scott, Ingrid U, Stewart, Michael W, Flynn, Harry W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019446/ https://www.ncbi.nlm.nih.gov/pubmed/27660409 http://dx.doi.org/10.2147/OPTH.S115546 |
Ejemplares similares
-
Emerging Pharmacotherapies for Diabetic Macular Edema
por: Javey, Golnaz, et al.
Publicado: (2012) -
Pharmacology of Corticosteroids for Diabetic Macular Edema
por: Whitcup, Scott M., et al.
Publicado: (2018) -
Corticosteroids for Diabetic Macular Edema
por: Chawan-Saad, Jorge, et al.
Publicado: (2019) -
Corticosteroid Treatment in Diabetic Macular Edema
por: Nurözler Tabakcı, Burcu, et al.
Publicado: (2017) -
INTRAVITREAL CORTICOSTEROIDS IN DIABETIC MACULAR EDEMA: Pharmacokinetic Considerations
por: Yang, Yit, et al.
Publicado: (2015)